TP53 (phospho S20) monoclonal antibody, clone 17B6-抗体-抗体-生物在线

产品名称： TP53 (phospho S20) monoclonal antibody, clone 17B6

英文名称： TP53 (phospho S20) monoclonal antibody, clone 17B6

产品编号： MAB0658

产品价格： null

产品产地：台湾

品牌商标： Abnova

更新时间： null

使用范围：

亚诺法生技股份有限公司（Abnova)

进入展台

Immunogen:
Synthetic phosphopeptide corresponding to residues surrounding S20 of human TP53.

Storage Instruction:
Store at -20°C. For long term storage store at -80°C.
Aliquot to avoid repeated freezing and thawing.

Recommend Usage:
Western Blot (1 ug/mL)
The optimal working dilution should be determined by the end user.

Western Blot
Identification of TP53 phospho-Ser20 with TP53 (phospho-S20) monoclonal antibody, clone 17B6 (Cat # MAB0658) by Western blotting. The lysates of H1299 cells (TP53 non-producing) transfected either with Flag vector (left lane) , Flag-TP53 (wild-type) expressing plasmid (middle lane) or Flag-TP53 mutant (Ser20) expressing plasmid (right lane) were immunoprecipitated with anti-Flag antibody and then analyzed by westernbotting with TP53 (phospho-S20) monoclonal antibody, clone 17B6, (upper panel) or with pantropic p-53 antibody (lower panel).

Gene Summary:
This gene encodes tumor protein p53, which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation, DNA-binding, and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion, and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor activity. Alterations of this gene occur not only as somatic mutations in human malignancies, but also as germline mutations in some cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative promoters and multiple alternative splicing have been found. These variants encode distinct isoforms, which can regulate p53 transcriptional activity. [provided by RefSeq

Other Designations:
p53 antigen,p53 transformation suppressor,p53 tumor suppressor,phosphoprotein p53,transformation-related protein 53